Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis
Standard of care for locally advanced cervical cancer (LACC) includes external beam radiotherapy (EBRT) with concomitant chemotherapy and image-guided adaptive brachytherapy (IGABT) [1]. The use of IGABT has brought improved disease control and overall survival, as well as decreased morbidity compared to two-dimensional (2D) brachytherapy (BT) [2] –[9].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Sofia Spampinato, Lars U. Fokdal, Richard P ötter, Christine Haie-Meder, Jacob C. Lindegaard, Maximilian P. Schmid, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Umesh Mahantshetty, Barbara Segedin, Kjersti Bruheim, Peter Hoskin, Bhavana Rai, Fleur Huang, R Tags: Original Article Source Type: research
More News: Bladder Cancer | Bleeding | Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Cystitis | External Beam Therapy | Radiology